Literature DB >> 18392695

Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis.

Gianfranco Lessiani1, Angela Falco, Elvira Nicolucci, Giancarlo Rolandi, Giovanni Davì.   

Abstract

Factor XII deficiency is associated with increased risk for both arterial and venous thrombosis. We describe a case of DVT involving superficial femoral and popliteal vein occurred following total hip replacement and despite prophylaxis with low molecular weight heparin in a subject with previous acute myocardial infarction (AMI). Tests of haemostasis documented a slightly prolonged activated partial thromboplastin time (APTT) (45'') due to mild factor XII deficiency (clotting activity 32%). A therapeutic dose of enoxaparin was started, together with warfarin therapy. The patient was advised to continue oral anticoagulation indefinitely. Although cases of both venous and arterial thrombosis in carriers of severe factor XII deficiency have been already reported, to our knowledge this is the first case in the literature occurred in a carrier of partial factor XII deficiency. In conclusion, factor XII deficiency should be suspected if a patient presents with recurrent arterial and/or venous thrombosis and prolonged APTT. If this defect is diagnosed, in the presence of a history of thrombotic events, lifelong anticoagulation could be considered.

Entities:  

Mesh:

Year:  2008        PMID: 18392695     DOI: 10.1007/s11239-008-0222-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  23 in total

1.  Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency.

Authors:  Keiko Ishii; Shuji Oguchi; Takanori Moriki; Yoko Yatabe; Eiko Takeshita; Mitsuru Murata; Yasuo Ikeda; Kiyoaki Watanabe
Journal:  Blood Coagul Fibrinolysis       Date:  2004-07       Impact factor: 1.276

2.  Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.

Authors:  H P Kohler; A M Carter; M H Stickland; P J Grant
Journal:  Thromb Haemost       Date:  1998-01       Impact factor: 5.249

3.  Risk factors for deep venous thrombosis of the upper extremities.

Authors:  D Pandita; P Steen; A Potti
Journal:  Ann Intern Med       Date:  1997-12-15       Impact factor: 25.391

4.  Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.

Authors:  Carine J M Doggen; Frits R Rosendaal; Joost C M Meijers
Journal:  Blood       Date:  2006-08-24       Impact factor: 22.113

5.  Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency--a study on 73 subjects from 14 Swiss families.

Authors:  S Zeerleder; M Schloesser; M Redondo; W A Wuillemin; W Engel; M Furlan; B Lämmle
Journal:  Thromb Haemost       Date:  1999-10       Impact factor: 5.249

6.  Identification and characterization of two novel mutations (Q421 K and R123P) in congenital factor XII deficiency.

Authors:  T Kanaji; S Kanaji; K Osaki; M Kuroiwa; M Sakaguchi; K Mihara; Y Niho; T Okamura
Journal:  Thromb Haemost       Date:  2001-12       Impact factor: 5.249

7.  Association after linkage analysis indicates that homozygosity for the 46C-->T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis.

Authors:  Isabel Tirado; José Manuel Soria; José Mateo; Artur Oliver; Juan Carlos Souto; Amparo Santamaria; Rosa Felices; Montserrat Borrell; Jordi Fontcuberta
Journal:  Thromb Haemost       Date:  2004-05       Impact factor: 5.249

8.  The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors.

Authors:  W M Halbmayer; A Haushofer; R Schön; C Mannhalter; E Strohmer; K Baumgarten; M Fischer
Journal:  Thromb Haemost       Date:  1994-01       Impact factor: 5.249

9.  Factor XII clotting activity and antigen levels in patients with thromboembolic disease.

Authors:  R von Känel; W A Wuillemin; M Furlan; B Lämmle
Journal:  Blood Coagul Fibrinolysis       Date:  1992-10       Impact factor: 1.276

Review 10.  The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature.

Authors:  A Girolami; M L Randi; S Gavasso; A M Lombardi; F Spiezia
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

View more
  6 in total

Review 1.  Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

2.  Relationship between factor XII deficiency and thrombosis: the debate is still open?

Authors:  Gianfranco Lessiani; Angela Falco; Elvira Nicolucci; Giancarlo Rolandi; Giovanni Davì
Journal:  J Thromb Thrombolysis       Date:  2009-04-08       Impact factor: 2.300

3.  The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified.

Authors:  Antonio Girolami; Pamela Scarparo; Silvia Vettore
Journal:  J Thromb Thrombolysis       Date:  2009-03-13       Impact factor: 2.300

4.  Nighttime aircraft noise impairs endothelial function and increases blood pressure in patients with or at high risk for coronary artery disease.

Authors:  Frank Schmidt; Kristoffer Kolle; Katharina Kreuder; Boris Schnorbus; Philip Wild; Marlene Hechtner; Harald Binder; Tommaso Gori; Thomas Münzel
Journal:  Clin Res Cardiol       Date:  2014-08-22       Impact factor: 5.460

Review 5.  The Effects of the Contact Activation System on Hemorrhage.

Authors:  Fabrício Simão; Edward P Feener
Journal:  Front Med (Lausanne)       Date:  2017-07-31

Review 6.  Environmental stressors and cardio-metabolic disease: part II-mechanistic insights.

Authors:  Thomas Münzel; Mette Sørensen; Tommaso Gori; Frank P Schmidt; Xiaoquan Rao; Frank R Brook; Lung Chi Chen; Robert D Brook; Sanjay Rajagopalan
Journal:  Eur Heart J       Date:  2017-02-21       Impact factor: 29.983

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.